Abstract
To the Editors: Pulmonary arterial hypertension (PAH) results from chronic obstruction of small pulmonary arteries, leading to right ventricular failure and ultimately death. PAH is a severe complication, known to be related to HIV infection [1]. The frequency of PAH in HIV patients is strikingly higher than in the general population and the fourth-leading cause of PAH in the French registry [2]. The incidence of PAH related to HIV (PAH-HIV) has not decreased over time, despite efficient anti-retroviral therapy (ART) [3]. Since its description in 1987, PAH-HIV has been well characterised and multiple therapeutic strategies have been proposed, but no full recovery has yet been published. Here, …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
